(Q54665285)

English

Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

pattern recognition

1 reference

based on heuristic

inferred from title

Per Soelberg Sørensen

3

object named as

Per Soelberg Sørensen

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

author name string

Christian Enevold

1

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Annette B Oturai

2

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Lars P Ryder

4

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Nils Koch-Henriksen

5

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Klaus Bendtzen

6

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

publication date

1 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

16

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

8

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

942-949

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Defining interferon beta response status in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Clinical characteristics of responders to interferon therapy for relapsing MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Follicular B helper T cells in antibody responses and autoimmunity.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

High mobility group box 1 protein interacts with multiple Toll-like receptors

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Anti-IFN BAb and NAb antibodies: a minireview

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

dbSNP: the NCBI database of genetic variation

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

PowerMarker: an integrated analysis environment for genetic marker analysis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

The genetic epidemiology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Linkage disequilibrium analysis of chromosome 12q14-15 in multiple sclerosis: delineation of a 118-kb interval around interferon-gamma (IFNG) that is involved in male versus female differential susceptibility.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Toll-like receptor stimulation as a third signal required for activation of human naive B cells.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Toll-like receptor heterodimer variants protect from childhood asthma

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Analysis of an IFN- gamma gene (IFNG) Polymorphism in Multiple Sclerosis in Europe: Effect of Population Structure on Association with Disease

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Interferon-? gene polymorphism-associated risk for multiple sclerosis in sardinia

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Letter to the editor

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1177%2F1352458510373264

21 January 2018

Identifiers

10.1177/1352458510373264

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20595247

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54665285&oldid=1511019526"